Status:
UNKNOWN
Supernormal Oxygen Delivery for Patients With Severe Burns
Lead Sponsor:
Guangzhou Red Cross Hospital
Conditions:
Burn Surgery
Dobutamine
Eligibility:
All Genders
18-60 years
Phase:
EARLY_PHASE1
Brief Summary
This is a randomized double-blinded study to investigate in which the groups are designated as the control group and the goal-directed fluid therapy group to further evaluate significant differences i...
Detailed Description
This is a randomized double-blinded study to investigate the effect of control group and the goal-directed fluid therapy group on complications during surgery of the burn patients. The groups are desi...
Eligibility Criteria
Inclusion
- Severe burn patients
Exclusion
- Patients or families refuse to sign consent
Key Trial Info
Start Date :
February 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05241912
Start Date
February 28 2022
End Date
June 1 2023
Last Update
February 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangzhou Red cross hospital
Guangzhou, Guangdong, China, 510220